Extramural cross‐validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability
The DOI matches its Crossref record; 11 of the 12 references it cites were found in a registry or an index.
Abstract
The generalizability of the Mayo model for predicting survival in individual primary biliary cirrhosis patients without liver transplantation was tested and confirmed. The model was applied to a data base of patients from the New England Medical Center Hospitals (n = 141) and the Scott and White Clinic (n = 35) and found to predict their survival accurately. It was also shown to be accurate for Mayo primary biliary cirrhosis patients with very advanced disease (n = 30), those with less than a 33% chance of surviving 12 months. The analyses confirmed that the addition of histologic stage did not significantly improve the predictive power of the model (p > 0.10). We suggest that the Mayo model is a practical tool for clinical management and decision making.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The bilirubin level is the best predictor of survival and is the most important component in all mathematical models of prognosis in PBC.(71,76)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [76]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
A class of rank test procedures for censored survival data
HARRINGTON, D. P., & FLEMING, T. R. (1982) · Biometrika · doi:10.1093/biomet/69.3.553 · Cited by 1,184
Self-citationPrognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816 · cited 4×
“the three models were highly correlated in their assessment of patient risk (3).”
BackgroundMethodInfluentialSelf-citationStaging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753
A Large Sample Study of Cox's Regression Model
Tsiatis, A. A. (1981) · The Annals of Statistics · doi:10.1214/aos/1176345335 · Cited by 476
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis
Christensen, E., Neuberger, J., Crowe, J., Altman, D. G., Popper, H., Portmann, B., Doniach, D., Ranek, L., Tygstrup, N., & Williams, R. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90213-6 · Cited by 423
Roll, J., Boyer, J. L., Barry, D., & Klatskin, G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198301063080101 · Cited by 417
A Prospective Trial of Colchicine for Primary Biliary Cirrhosis
Kaplan, M. M., Alling, D. W., Zimmerman, H. J., Wolfe, H. J., Sepersky, R. A., Hirsch, G. S., Elta, G. H., Glick, K. A., & Eagen, K. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612043152304 · Cited by 313
Self-citationEfficacy of Liver Transplantation in Patients with Primary Biliary Cirrhosis
Markus, B. H., Dickson, E. R., Grambsch, P. M., Fleming, T. R., Mazzaferro, V., Klintmalm, G. B. G., Wiesner, R. H., Van Thiel, D. H., & Starzl, T. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906293202602 · Cited by 234
Self-citationTrial of Penicillamine in Advanced Primary Biliary Cirrhosis
Dickson, E. R., Fleming, T. R., Wiesner, R. H., Baldus, W. P., Fleming, C. R., Ludwig, J., & McCall, J. T. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504183121602 · Cited by 165
Self-citation
Research works printed but not linked: 1
- Cox, 1972, J R Stat Soc [B], 34, 187
Cited by
A Model to Predict Survival in Patients With End–Stage Liver Disease
Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W., Therneau, T. M., Kosberg, C. L., D'Amico, G., Dickson, R. E., & Kim, R. W. (2001) · Hepatology · doi:10.1053/jhep.2001.22172 · Cited by 4,975
Self-citationHoeting, J. A., Madigan, D., Raftery, A. E., & Volinsky, C. T. (1999) · Statistical Science · doi:10.1214/ss/1009212519 · Cited by 4,118
(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Self-citationLindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
Metadata
- Authors
- Grambsch, P. M., Dickson, R. E., Kaplan, M., Lesage, G., Fleming, T. R., & Langworthy, A. L.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Grambsch, Patricia M.
- ORCID
- Fleming, Thomas R.
- Venue
- Hepatology
- Published
- 1989-11
- Volume
- 10
- Issue
- 5
- Pages
- 846-850
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2020104402
- Cited by
- 107
- References
- 12
- Citations by year
- 2026: 1 · 2021: 2 · 2019: 1 · 2018: 3 · 2016: 1 · 2015: 3 · 2014: 4 · 2013: 5 · 2012: 1
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 9435 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AM-34238)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- primary biliary cirrhosis, survival prediction, model generalization, advanced disease, clinical decision-making
- MeSH terms
- Academic Medical Centers, Aged, Decision Support Techniques, Humans, Liver Cirrhosis, Biliary, Middle Aged, Minnesota, Prognosis, Risk Factors, United States, Meta-Analysis as Topic, Multicenter Studies as Topic, Survival Rate, Proportional Hazards Models, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.